OS Therapies Incorporated (OSTX) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

OS Therapies Incorporated (OSTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $84.2M, listed on AMEX, employing roughly 4 people, carrying a beta of -1.34 to the broader market. OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Led by Paul A. Romness, public since 2024-08-01.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for OSTX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →